MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    A Systematic Review of the Psychometric Properties of Psychosis Rating Scales in Neurodegenerative Conditions

    P.S Malhotra, Y.M Wan, E.K Tan (London, United Kingdom)

    Objective: To provide an overview of psychosis rating scales validated in specific neurodegenerative disease populations and compare psychometric characteristics of the validated psychosis scales. Background:…
  • MDS Virtual Congress 2020

    Impact of Deep Brain Stimulation on Fall Risk

    K. Lyons, V. Pahwa, R. Pahwa (Kansas City, KS, USA)

    Objective: To compare fall risk in Parkinson’s disease patients with and without deep brain stimulation of the subthalamic nucleus. Background: The prevention of falls is…
  • MDS Virtual Congress 2020

    Evaluation of the Body Weight Changes and Food Addiction in Parkinson’s Disease patient with Deep Brain Stimulation

    I. Yakisikli, M. Saka, A. Zirh, B. Bolluk Kilic (Ankara, Turkey)

    Objective: The aim of this study is to evaluate Parkinson’s disease patient’s body weight changes after Deep Brain Stimulation (DBS) and to search the existence…
  • MDS Virtual Congress 2020

    A day in the life of Parkinson’s: Using passive monitoring to characterize the disease at home

    C. Tarolli, Z. Kabelac, T. Myers, E. Waddell, H. Rahul, R. Hristov, P. Auinger, T. Nordahl, E.R Dorsey, T. Ellis, D. Katabi (Rochester, NY, USA)

    Objective: To characterize the home lives of individuals with Parkinson's disease (PD) using a passive radio wave sensor with a focus on motor, non-motor, and…
  • 2019 International Congress

    Efficacy and safety of zonisamide in patients with dementia with Lewy bodies with parkinsonism: pooled analysis of phase 2 and 3 trials

    J. Goldman, K. Hasegawa, T. Odawara, K. Kochi, H. Maruyama, O. Konishi, S. Toya, K. Kosaka, M. Murata, I. Mckeith (Chicago, IL, USA)

    Objective: To characterize the efficacy and safety of zonisamide (ZNS) in patients with dementia with Lewy bodies (DLB) with parkinsonism, a pooled analysis of two…
  • 2019 International Congress

    Biphasic Dyskinesias in Parkinson’s disease Patients treated with Levodopa/Carbidopa Intestinal Gel: Insights from a Multicenter Retrospective Analysis

    M. Marano, T. Naranian, L. Di Biase, A. Di Santo, R. Arca, G. Cossu, P. Marano, V. Di Lazzaro, A. Fasano (Rome, Italy)

    Objective: We aimed to characterize Parkinson's disease (PD) patients who developed the onset of new troublesome dyskinesias after Levodopa-Carbidopa Intestinal Gel (LCIG) initiation. We were…
  • 2019 International Congress

    Parkinson’s disease and intermittent hypoxia training: beneficial or harmful?

    M. Sharifi-Bonab, J. Sesink, B. Bloem, D. Devos, J. Deguil, C. Moreau (Nijmegen, Netherlands)

    Objective: To systematically review the scientific evidence for beneficial or harmful effects of intermittent hypoxia that were used in Parkinson’s disease (PD) in clinical and…
  • 2019 International Congress

    Effects of safinamide and rasagiline on in vivo glutamate release in 6-OHDA hemilesioned rats

    CA. Pisanò, A. Brugnoli, S. Novello, C. Caccia, C. Keywood, E. Melloni, G. Padoani, S. Vailati, M. Morari (Ferrara, Italy)

    Objective: To investigate the effects of safinamide (saf) and rasagiline on in vivo glutamate (Glu) release in the 6-hydroxydopamine (6-OHDA) hemilesioned rat model of Parkinson’s…
  • 2019 International Congress

    PRECISE-PD: From pathophysiology to precision medicine for Parkinson’s disease

    JC. Corvol, S. Durrleman, S. Lehericy, D. Devos, W. Meissner, E. Bezard, D. Grosset, H. Morris, O. Monchy, EA. Fon, F. Durif, F. Tubach, Y. de Rycke, O. Rascol (Paris, France)

    Objective: To propose a mechanism-based progression model of Parkinson’s disease (PD) by combining genetic, imaging, and longitudinal clinical data from a large cohort of patients.…
  • 2019 International Congress

    Parkinson’s disease Polygenic Risk Factor Scores in Patients with Inflammatory Bowel Disease

    H. Maghzi, D. Li, E. Hogg, A. Garland-Becerra, E. Tan, A. Maghzi, D. Mcgovern, M. Tagliati (Los Angeles, CA, USA)

    Objective: To assess the genetic risk factors for Parkinson’s disease (PD) in a large population of patients with inflammatory bowel disease (IBD), as compared to…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • #24475 (not found)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley